Dupilumab (dupilumab) is a potentially first-in-class, fully human monoclonal antibody against IL-4 receptor alpha (IL-4Ralpha) that inhibits IL-4 and IL-13 signaling and can be used in studies related to atopic dermatitis and asthma.
Reinheit:
99.0%
CAS Nummer:
[1190264-60-8]
Target-Kategorie:
IL Receptor/Related
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten